a developer of an anticalin-brand protein technology
Industry Biotechnology
A.I.dvisor indicates that over the last year, PIRS has been closely correlated with CDTX. These tickers have moved in lockstep 96% of the time. This A.I.-generated data suggests there is a high statistical probability that if PIRS jumps, then CDTX could also see price increases.
Ticker / NAME | Correlation To PIRS | 1D Price Change % | ||
---|---|---|---|---|
PIRS | 100% | -0.12% | ||
CDTX - PIRS | 96% Closely correlated | +3.35% | ||
NCNA - PIRS | 95% Closely correlated | -1.25% | ||
NBY - PIRS | 95% Closely correlated | -8.67% | ||
SNPX - PIRS | 94% Closely correlated | -8.73% | ||
RNAC - PIRS | 94% Closely correlated | +1.12% | ||
More |
Ticker / NAME | Correlation To PIRS | 1D Price Change % |
---|---|---|
PIRS | 100% | -0.12% |
protein therapeutics theme (6 stocks) | 28% Poorly correlated | -3.89% |
PIRS theme (22 stocks) | 17% Poorly correlated | -2.84% |
biotechnology theme (238 stocks) | 8% Poorly correlated | -1.80% |
drugs theme (254 stocks) | 7% Poorly correlated | -1.72% |
generic products theme (72 stocks) | -10% Poorly correlated | -0.60% |